CONTRIBUTORS

Neuroinfectious Disease p. 1256-1260 October 2018, Vol.24, No.5 doi: 10.1212/01.CON.0000546584.41336.d9
CONTRIBUTORS
BROWSE ARTICLES
Article Level Metrics

Joseph R. Zunt, MD, MPH, Guest Editor

Professor, Departments of Neurology, Global Health, Epidemiology, and Medicine (Infectious Diseases), University of Washington, Seattle, Washington

Relationship Disclosure: Dr Zunt receives research/grant support from the National Institutes of Health (2D43 TW009345-06, 1D43TW009137-01A1, 1D43TW009375-01A1, 1D43TW009763- 01).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Zunt reports no disclosure.

Kelly J. Baldwin, MD

Neurology Residency Program Director, Director Neuroinfectious Disease Program, Assistant Professor, Geisinger Commonwealth School of Medicine, Danville, Pennsylvania

Relationship Disclosure: Dr Baldwin reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Baldwin discusses the unlabeled/investigational use of acyclovir, aloe vera, amitriptyline, controlled-release morphine, controlled-release oxycodone, diazepam, divalproex sodium, ganciclovir, foscarnet, levetiracetam, lidocaine, lorazepam, methylprednisolone, nortriptyline, oxcarbazepine, prednisone, tramadol, and trolamine salicylate for the treatment of herpesvirus infections.

Aaron L. Berkowitz, MD, PhD

Director, Global Neurology Program, Brigham and Women’s Hospital; Associate Professor of Neurology, Harvard Medical School, Boston, Massachusetts

Relationship Disclosure: Dr Berkowitz receives publishing royalties from McGraw-Hill Education, MedMaster Inc, and Oxford University Press.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Berkowitz reports no disclosure.

Tracey A. Cho, MD, FAAN

Clinical Associate Professor of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Relationship Disclosure: Dr Cho has received personal compensation as a consultant for Optum, Inc.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Cho discusses the unlabeled/investigational use of immunomodulatory medications including corticosteroids and oral steroid-sparing agents for the management of inflammation in neurocysticercosis and neuroschistosomiasis.

Felicia Chow, MD, MAS

Assistant Professor, Weill Institute for Neurosciences, Department of Neurology and Division of Infectious Diseases, University of California, San Francisco at Zuckerberg San Francisco General Hospital, San Francisco, California

Relationship Disclosure: Dr Chow has received personal compensation for speaking engagements from the University of California, San Francisco, for Recent Advances in Neurology and receives research/grant support from the National Institutes of Health (K23NS105575, R21TW010148).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Chow reports no disclosure.

Christopher L. Cummings, MD

Medical Stroke Director; Assistant Professor, Geisinger Commonwealth School of Medicine, Danville, Pennsylvania

Relationship Disclosure: Dr Cummings reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Cummings discusses the unlabeled/investigational use of acyclovir, aloe vera, amitriptyline, controlled-release morphine, controlled-release oxycodone, diazepam, divalproex sodium, ganciclovir, foscarnet, levetiracetam, lidocaine, lorazepam, methylprednisolone, nortriptyline, oxcarbazepine, prednisone, tramadol, and trolamine salicylate for the treatment of herpesvirus infections.

Larry E. Davis, MD

Distinguished Professor of Neurology, University of New Mexico School of Medicine; Chief, Neurology Service, New Mexico VA Medical Center, Albuquerque, New Mexico

Relationship Disclosure: Dr Davis receives publishing royalties from Springer Science+Business Media, LLC.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Davis reports no disclosure.

John J. Halperin, MD, FAAN, FIDSA

Chair, Department of Neurosciences, Overlook Medical Center, Summit, New Jersey; Professor, Neurology and Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania

Relationship Disclosure: Dr Halperin serves on the editorial board of Neurology and has received personal compensation for serving as a section editor for Current Neurology and Neuroscience Reports and as a speaker for the American Academy of Neurology, Infectious Diseases Society of America, and University of Kansas Medical Center. Dr Halperin receives royalties from CABI and UpToDate, Inc and holds stock in Abbott Laboratories, AbbVie Inc, and Johnson & Johnson. Dr Halperin has given expert medical testimony in various medical malpractice cases related to Lyme disease.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Halperin reports no disclosure.

Joseph S. Kass, MD, JD, FAAN

Associate Dean, Office of Student Affairs; Professor of Neurology, Psychiatry, and Medical Ethics; Director, Alzheimer’s Disease and Memory Disorders Center, Baylor College of Medicine; Chief of Neurology, Ben Taub General Hospital, Houston, Texas

Relationship Disclosure: Dr Kass serves as associate editor of ethical and medicolegal issues for Continuum, as an associate editor for Continuum Audio, as a neurology section editor of Ferri’s Clinical Advisor for Elsevier, and as co-editor of Neurology Secrets, Sixth Edition. Dr Kass has received personal compensation for CME lectures from Pri-Med Medical Group and has received personal compensation as a medicolegal consultant in legal cases involving criminal proceedings, malpractice, and personal injury.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Kass reports no disclosure.

Jennifer L. Lyons, MD

Associate Medical Director, Biogen, Inc, Boston, Massachusetts

Relationship Disclosure: Dr Lyons has provided expert medical testimony on herpes encephalitis.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Lyons reports no disclosure.

Amy A. Pruitt, MD

Professor of Neurology, Vice Chair for Education, University of Pennsylvania, Philadelphia, Pennsylvania

Relationship Disclosure: Dr Pruitt serves on the editorial board of Neurology Clinical Practice.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Pruitt discusses therapies for the treatment of lymphoma arising from immunosuppression, none of which are approved by the US Food and Drug Administration.

Rachel V. Rose, JD, MBA

Attorney, Rachel V. Rose Attorney at Law PLLC; Affiliated Faculty, Baylor College of Medicine, Houston, Texas

Relationship Disclosure: Ms Rose serves on the editorial board of BC Advantage and receives book royalties from the American Bar Association.

Unlabeled Use of Products/Investigational Use Disclosure: Ms Rose reports no disclosure.

Deanna Saylor, MD, MHS

Assistant Professor of Neurology, Director, Johns Hopkins Global Neurology Program, Johns Hopkins University School of Medicine, Baltimore, Maryland; Honorary Lecturer, University of Zambia School of Medicine, Lusaka, Zambia

Relationship Disclosure: Dr Saylor receives research/grant support from the National Institutes of Health (P30MH07565673-11A1, R01 MH099733, NS081196091, P30AI094189-01A1, L30 NS088658, R25 NS065729-05S2, R25 MH080661-08), Sara’s Wish Foundation, and the United States Department of State (Fulbright Scholar Award).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Saylor discusses recent or ongoing clinical trials of intranasal insulin, maraviroc, and paroxetine for treatment of human immunodefi ciency virus–associated neurocognitive disorder and the off-label use of interleukin-7, mirtazapine, and topotecan for the treatment of progressive multifocal leukoencephalopathy.

James J. Sejvar, MD

Neuroepidemiologist, Centers for Disease Control and Prevention, Atlanta, Georgia

Relationship Disclosure: Dr Sejvar is an employee of the Centers for Disease Control and Prevention.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Sejvar reports no disclosure.

Kiran T. Thakur, MD

Winifred Mercer Pitkin, MD Assistant Professor of Neurology, Codirector, Community and Global Neurology Program, Columbia University Medical Center, New York, New York

Relationship Disclosure: Dr Thakur receives research/grant support from the National Institutes of Health (K23NS105935).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Thakur reports no disclosure.

Michael R. Wilson, MD, MAS

Assistant Professor, of Neurology, Debbie and Andy Rachleff Distinguished Professor of Neurology, University of California, San Francisco, Weill Institute for Neurosciences, San Francisco California

Relationship Disclosure: Dr Wilson receives research/grant support from Genentech, Inc, and the National Institute of Neurological Disorders and Stroke (K08NS096117).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Wilson reports no disclosure.

Self-Assessment and CME Test Writers

Douglas J. Gelb, MD, PhD, FAAN

Professor of Neurology, University of Michigan, Ann Arbor, Michigan

Relationship Disclosure: Dr Gelb receives royalties from MedLink, Oxford University Press, and UpToDate, Inc.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Gelb reports no disclosure.

Allyson R. Zazulia, MD

Professor of Neurology and Radiology, Associate Dean for Continuing Medical Education, Washington University, St. Louis, Missouri

Relationship Disclosure: Dr Zazulia reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Zazulia reports no disclosure.

© 2018 American Academy of Neurology